Ulcerative Colitis Clinical Trials in Chicago

Showing 701-720 of 806 trials

A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)

NCT00787995

This multicenter, multinational, longitudinal study will quantify endurance and respiratory function in subjects diagnosed with MPS IVA and will better characterize the spectrum of symptoms and biochemical abnormalities in MPS IVA disease over time.

MPS IV AMucopolysaccharidosis IVAMorquio A Syndrome

BioMarin Pharmaceutical353 participantsStarted Oct 2008

Oakland, California, United States • Chicago, Illinois, United States • Córdoba, Argentina +12 more locations

COMPLETEDNA2.2 miles

School-Based Mental Health Services for Urban Children

NCT00612690

This study will evaluate the effectiveness of school- and home-based mental health services and training modules in supporting learning and behavior in financially disadvantaged children who live in urban areas.

Conduct DisorderOppositional Defiant DisorderAttention Deficit Disorder With Hyperactivity

University of Illinois at Chicago482 participantsStarted Jun 2005

Chicago, Illinois, United States

COMPLETEDPhase 311 miles

Tiotropium / Respimat One-Year Study

NCT00168831

To evaluate the long term effects of treatment with two doses of Tiotropium delivered by the Respimat inhaler in patients with COPD.

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim1,007 participantsStarted Feb 2003

Birmingham, Alabama, United States • La Jolla, California, United States • Long Beach, California, United States +73 more locations

A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)

School-Based Mental Health Services for Urban Children

Tiotropium / Respimat One-Year Study

Ulcerative Colitis Trials in Other Cities

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

Tiotropium / Respimat One Year Study in COPD.

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

12 / 48 Week Pivotal PFT vs PBO in COPD I

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

A Multi-Center Study to Assess the Performance of Saturation Patterns.

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Improving Clinician Communication Skills (ICCS)

Other Conditions in Chicago